Dirinco SRL
2.9 FTEThe score of Dirinco shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +103 % Total assets +58 % Headcount (avg FTE) +61 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dirinco's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 103,463 € | ||||
| Equity | 776,976 € | ||||
| Cash | 182,656 € | ||||
| EBITDA | 154,317 € | ||||
| Total assets | €1.26m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 08 Sep 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
Dirinco's financial analysis
- Solvency61.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dirinco
Dirinco's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0434.246.729
- VAT number
- BE0434246729
- Peppol
- Registered · 0208:0434246729 · as of 02 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 May 1988
- Registered office
- 1853 Grimbergen
- Size
- Micro · 2.9 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Dirinco (SRL) has been based in Grimbergen since 1988, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 103,463 € and equity of 776,976 €; its revenue is not published. With 2.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 61.6%, above the median of its sector (46.0%).
Companies similar to Dirinco
Companies in the same business, of comparable size and area, outside its group.
- Laboratoires Forte Pharma Benelux Wholesale of other food Brussels · balance sheet €1.85m
- Laerdal Benelux Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €1.21m
- Amoena Benelux Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet €1.37m
- Epredia Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.24m
- Daxant Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.04m
- Aboca Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.24m
- AUXI Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.20m
- Mobilae België Wholesale of pharmaceutical and medical goods Sint-Martens-Latem · balance sheet €2.71m
Frequently asked questions about Dirinco
What is the revenue of Dirinco?
Dirinco files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dirinco?
In Belgium, the VAT number is the company number prefixed with BE: BE0434246729 for Dirinco, if the company is VAT-registered. Its company number (CBE) is 0434.246.729.
Where is the registered office of Dirinco?
According to the CBE register, the registered office of Dirinco is in 1853 Grimbergen.
What is the equity of Dirinco?
At the close of the 2025 financial year, the equity of Dirinco amounts to 776,976 €, a solvency of 61.6% of total assets.
How many people work at Dirinco?
2.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dirinco?
The register lists 2 active mandates at Dirinco. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dirinco
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →